- PR Newswire•9 hours agoIpsen Biopharmaceuticals, Inc. Announces Data Presentations at the 2016 Annual Meeting of the Child Neurology Society
ADR: IPSEY) (Ipsen), today announced that three abstracts were chosen for poster presentations during the annual meeting of the Child Neurology Society (CNS) being held in Vancouver, BC, October 26 – 29, 2016. "Following the recent FDA approval of Dysport® for the treatment of lower limb spasticity in children two years of age and older, we are proud to present related data at this year's Child Neurology Society Annual Meeting," said Cynthia Schwalm, EVP, North America Commercial Operations, Ipsen.
- PR Newswire•7 days agoIpsen Biopharmaceuticals, Inc. Announces Data Presentations at the Annual Meeting of the American Academy of Physical Medicine & Rehabilitation
BASKING RIDGE, N.J., Oct. 19, 2016 /PRNewswire/ -- Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY) (Ipsen), today announced that seventeen abstracts were chosen for poster ...
Ipsen S.A. (IPN.PA)
Paris - Paris Delayed Price. Currency in EUR
|Bid||53.26 x 46200|
|Ask||53.99 x 2000|
|Day's Range||60.87 - 63.31|
|52wk Range||45.31 - 63.97|
|1y Target Est||N/A|
|P/E Ratio (ttm)||22.37|
|Avg Vol (3m)||70,383|
|Dividend & Yield||N/A (N/A)|